Hiroko Shimada

Saitama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Feasibility Study on Development of a Collaborative Monitoring System between a Hospital and Community Pharmacy Using an Electronic Patient-Reported Outcome Application for Breast Cancer Outpatients Treated with Abemaciclib.

Feasibility Study on Development of a Collaborative Monitoring System between a Hospital and Community Pharmacy Using an Electronic Patient-Reported Outcome Application for Breast Cancer Outpatients Treated with Abemaciclib.

Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan

Published: April 01, 2026

Baseline Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in PD-L1-positive Advanced Triple-negative Breast Cancer With Immune-checkpoint-inhibitor Treatment.

Baseline Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in PD-L1-positive Advanced Triple-negative Breast Cancer With Immune-checkpoint-inhibitor Treatment.

Journal: Cancer diagnosis & prognosis

Published: March 17, 2026

Baseline peripheral blood immune markers associated with clinical outcomes in patients with advanced breast cancer treated with trastuzumab deruxtecan.

Baseline peripheral blood immune markers associated with clinical outcomes in patients with advanced breast cancer treated with trastuzumab deruxtecan.

Journal: BMC cancer

Published: February 06, 2026

Septic Pulmonary Embolism due to Methicillin-Resistant Staphylococcus aureus Bacteremia during Adjuvant Chemotherapy for Breast Cancer: A Case Report.

Septic Pulmonary Embolism due to Methicillin-Resistant Staphylococcus aureus Bacteremia during Adjuvant Chemotherapy for Breast Cancer: A Case Report.

Journal: Case reports in oncology

Published: January 04, 2026

Occult breast cancer showing a marked response to pembrolizumab plus gemcitabine and carboplatin therapy complicated by immune-related colitis: A case report.

Occult breast cancer showing a marked response to pembrolizumab plus gemcitabine and carboplatin therapy complicated by immune-related colitis: A case report.

Journal: Molecular and clinical oncology

Published: November 11, 2025

Association between tumor-infiltrating lymphocytes and oncotype DX estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 single gene scores in hormone receptor-positive/HER2-negative breast cancer.

Association between tumor-infiltrating lymphocytes and oncotype DX estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 single gene scores in hormone receptor-positive/HER2-negative breast cancer.

Journal: Frontiers in oncology

Published: August 01, 2025

G-CSF-induced Aortitis in an elderly woman successfully managed with prednisolone: a case report and literature review.

G-CSF-induced Aortitis in an elderly woman successfully managed with prednisolone: a case report and literature review.

Journal: Oxford medical case reports

Published: November 11, 2024

Comprehensive prognostic prediction of metastatic breast cancer treated with eribulin using blood‑based parameters and ratio.

Comprehensive prognostic prediction of metastatic breast cancer treated with eribulin using blood‑based parameters and ratio.

Journal: Molecular and clinical oncology

Published: August 05, 2023

Clinicopathological prognostic characteristics and long‑term outcomes of patients with breast cancer and collagen disorder in comparison to those without collagen disorder.

Clinicopathological prognostic characteristics and long‑term outcomes of patients with breast cancer and collagen disorder in comparison to those without collagen disorder.

Journal: Oncology letters

Published: May 29, 2023

Vimentin-positive invasive breast carcinoma of no special type: A breast carcinoma with lethal biological characteristics.

Vimentin-positive invasive breast carcinoma of no special type: A breast carcinoma with lethal biological characteristics.

Journal: Pathology international

Published: March 31, 2023

Correction to: Tumor budding and fibrotic focus-proposed grading system for tumor budding in invasive carcinoma no special type of the breast.

Correction to: Tumor budding and fibrotic focus-proposed grading system for tumor budding in invasive carcinoma no special type of the breast.

Journal: Virchows Archiv : an international journal of pathology

Published: December 29, 2022

A next-generation iPSC-derived forebrain organoid model of tauopathy with tau fibrils by AAV-mediated gene transfer.

A next-generation iPSC-derived forebrain organoid model of tauopathy with tau fibrils by AAV-mediated gene transfer.

Journal: Cell reports methods

Published: April 06, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026